Insulin or sulfonylurea treatments of the diabetics differentially affect erythrocyte membrane and serum enzymes and extent of protein glycosylation

Kunjan R Dave, T. H. Patol, S. S. Katyare

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Erythrocyte membrane protein glycosylation increased by 3.4 fold in diabetes, insulin or sulfonylurea treatment did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups including control. Erythrocyte membrane Na+,K+-ATPase activity decreased in the diabetics; only insulin treatment partly restored the activity. Erythrocyte membrane acetylcholinesterase activity decreased only in the sulfonylurea treated group. Serum butyrylcholinesterase activity was relatively low in the diabetic and insulin treated diabetic groups. The Km and Vmax of the two components of Na+,K+-ATPase from erythrocyte membranes were differently affected in the diabetic and the two treatment groups. The Vmax of acetylcholinesterase decreased only in the sulfonylurea treated group. Diabetic states resulted in decreased Vmax of components I and II of serum butyrylcholinesterase. In insulin-treated diabetics, component II was absent. Sulfonylurea group resembled diabetics. In vitro incubation with insulin differentially affected the Na+ K +-ATPase and serum butyrylcholinesterase activities.

Original languageEnglish
Pages (from-to)81-88
Number of pages8
JournalIndian Journal of Clinical Biochemistry
Volume16
Issue number1
StatePublished - Dec 1 2001

Fingerprint

Glycosylation
Erythrocyte Membrane
Butyrylcholinesterase
Insulin
Membranes
Adenosine Triphosphatases
Enzymes
Serum
Acetylcholinesterase
Proteins
Medical problems
Blood Proteins
Membrane Proteins
Control Groups
sodium-translocating ATPase

Keywords

  • Acetyl choline esterase
  • Butyryl chotine esterase
  • Diabetes mellitus
  • Erythrocyte membranes
  • Glycosylation
  • K+-ATPase
  • Na+

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

@article{550a930c8ac543deb954151f8009ed17,
title = "Insulin or sulfonylurea treatments of the diabetics differentially affect erythrocyte membrane and serum enzymes and extent of protein glycosylation",
abstract = "Erythrocyte membrane protein glycosylation increased by 3.4 fold in diabetes, insulin or sulfonylurea treatment did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups including control. Erythrocyte membrane Na+,K+-ATPase activity decreased in the diabetics; only insulin treatment partly restored the activity. Erythrocyte membrane acetylcholinesterase activity decreased only in the sulfonylurea treated group. Serum butyrylcholinesterase activity was relatively low in the diabetic and insulin treated diabetic groups. The Km and Vmax of the two components of Na+,K+-ATPase from erythrocyte membranes were differently affected in the diabetic and the two treatment groups. The Vmax of acetylcholinesterase decreased only in the sulfonylurea treated group. Diabetic states resulted in decreased Vmax of components I and II of serum butyrylcholinesterase. In insulin-treated diabetics, component II was absent. Sulfonylurea group resembled diabetics. In vitro incubation with insulin differentially affected the Na+ K +-ATPase and serum butyrylcholinesterase activities.",
keywords = "Acetyl choline esterase, Butyryl chotine esterase, Diabetes mellitus, Erythrocyte membranes, Glycosylation, K+-ATPase, Na+",
author = "Dave, {Kunjan R} and Patol, {T. H.} and Katyare, {S. S.}",
year = "2001",
month = "12",
day = "1",
language = "English",
volume = "16",
pages = "81--88",
journal = "Indian Journal of Clinical Biochemistry",
issn = "0970-1915",
publisher = "Springer India",
number = "1",

}

TY - JOUR

T1 - Insulin or sulfonylurea treatments of the diabetics differentially affect erythrocyte membrane and serum enzymes and extent of protein glycosylation

AU - Dave, Kunjan R

AU - Patol, T. H.

AU - Katyare, S. S.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Erythrocyte membrane protein glycosylation increased by 3.4 fold in diabetes, insulin or sulfonylurea treatment did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups including control. Erythrocyte membrane Na+,K+-ATPase activity decreased in the diabetics; only insulin treatment partly restored the activity. Erythrocyte membrane acetylcholinesterase activity decreased only in the sulfonylurea treated group. Serum butyrylcholinesterase activity was relatively low in the diabetic and insulin treated diabetic groups. The Km and Vmax of the two components of Na+,K+-ATPase from erythrocyte membranes were differently affected in the diabetic and the two treatment groups. The Vmax of acetylcholinesterase decreased only in the sulfonylurea treated group. Diabetic states resulted in decreased Vmax of components I and II of serum butyrylcholinesterase. In insulin-treated diabetics, component II was absent. Sulfonylurea group resembled diabetics. In vitro incubation with insulin differentially affected the Na+ K +-ATPase and serum butyrylcholinesterase activities.

AB - Erythrocyte membrane protein glycosylation increased by 3.4 fold in diabetes, insulin or sulfonylurea treatment did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups including control. Erythrocyte membrane Na+,K+-ATPase activity decreased in the diabetics; only insulin treatment partly restored the activity. Erythrocyte membrane acetylcholinesterase activity decreased only in the sulfonylurea treated group. Serum butyrylcholinesterase activity was relatively low in the diabetic and insulin treated diabetic groups. The Km and Vmax of the two components of Na+,K+-ATPase from erythrocyte membranes were differently affected in the diabetic and the two treatment groups. The Vmax of acetylcholinesterase decreased only in the sulfonylurea treated group. Diabetic states resulted in decreased Vmax of components I and II of serum butyrylcholinesterase. In insulin-treated diabetics, component II was absent. Sulfonylurea group resembled diabetics. In vitro incubation with insulin differentially affected the Na+ K +-ATPase and serum butyrylcholinesterase activities.

KW - Acetyl choline esterase

KW - Butyryl chotine esterase

KW - Diabetes mellitus

KW - Erythrocyte membranes

KW - Glycosylation

KW - K+-ATPase

KW - Na+

UR - http://www.scopus.com/inward/record.url?scp=77950454087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950454087&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77950454087

VL - 16

SP - 81

EP - 88

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -